Likewise, B-I09 significantly reduced the tumor burden in CARM1-high, but not in CARM1-low, HGSOC patient-derived xenograft (PDX) models (Fig. 6d, e and Supplementary Fig. 5c, d). The gene discussed is CARM1; the disease is neoplasm.